In the complex environment of today’s life sciences industries, stakeholders and their counsel face an increasing number of commercial disputes related to intellectual property (IP) and technology with a significant business, financial and reputational impact.
Such disputes require a carefully integrated dispute resolution strategy to control costs and to protect the value of technologies and associated IP rights. Dispute resolution strategies may include out-of-court dispute resolution mechanisms, such as WIPO Mediation or Arbitration.
The Conference will provide an overview of the contractual framework of collaborations in life sciences, relevant IP matters, actual and potential disputes, and options to resolve such disputes. Renowned speakers will discuss their experience of court litigation, mediation and arbitration in major life sciences markets in Europe, the United States of America and the BRIC countries. They will focus on issues such as cost, time and enforceability of court litigation as compared to procedures under the WIPO Expedited Arbitration, Arbitration and Mediation Rules.
The faculty for this Conference will consist of speakers from industry, law firms and science institutions.
The program will consist of sessions devoted to the following subjects:
- Contracts, Intellectual Property and Disputes in Life Sciences
- Resolving Life Sciences Disputes – Court Litigation
- Session 1 – Europe: the Unified Patent Court, France, Germany and UK
- Session 2 – BRIC countries and United States of America
- Resolving Life Sciences Disputes – Mediation and Arbitration
- Session 1 – WIPO Mediation and Arbitration
- Session 2 – Focus Mediation
- Session 3 – Focus Arbitration
- Roundtable – Best Practices in Life Sciences Dispute Resolution
Who should attend?
The Conference is tailored for representatives from industry, lawyers, patent attorneys and trademark attorneys, IP managers, technology transfer professionals, universities, research institutes and public organizations involved in life sciences.